Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03520517
Recruitment Status : Completed
First Posted : May 9, 2018
Last Update Posted : August 22, 2019
Cognitive Research Corporation
Information provided by (Responsible Party):
Biohaven Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 8, 2018
Actual Study Completion Date : October 8, 2018